These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35163553)

  • 1. Different Cell Responses to Hinokitiol Treatment Result in Senescence or Apoptosis in Human Osteosarcoma Cell Lines.
    Yang SC; Chen HY; Chuang WL; Wang HC; Hsieh CP; Huang YF
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
    Li LH; Wu P; Lee JY; Li PR; Hsieh WY; Ho CC; Ho CL; Chen WJ; Wang CC; Yen MY; Yang SM; Chen HW
    PLoS One; 2014; 9(8):e104203. PubMed ID: 25105411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hinokitiol Exhibits Antitumor Properties through Induction of ROS-Mediated Apoptosis and p53-Driven Cell-Cycle Arrest in Endometrial Cancer Cell Lines (Ishikawa, HEC-1A, KLE).
    Chen HY; Cheng WP; Chiang YF; Hong YH; Ali M; Huang TC; Wang KL; Shieh TM; Chang HY; Hsia SM
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34361036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hinokitiol induces cell death and inhibits epidermal growth factor-induced cell migration and signaling pathways in human cervical adenocarcinoma.
    Wang CC; Chen BK; Chen PH; Chen LC
    Taiwan J Obstet Gynecol; 2020 Sep; 59(5):698-705. PubMed ID: 32917321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
    Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Butein induces cellular senescence through reactive oxygen species-mediated p53 activation in osteosarcoma U-2 OS cells.
    Hsu YK; Chen HY; Wu CC; Huang YC; Hsieh CP; Su PF; Huang YF
    Environ Toxicol; 2021 May; 36(5):773-781. PubMed ID: 33325610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hinokitiol Inhibits Migration of A549 Lung Cancer Cells via Suppression of MMPs and Induction of Antioxidant Enzymes and Apoptosis.
    Jayakumar T; Liu CH; Wu GY; Lee TY; Manubolu M; Hsieh CY; Yang CH; Sheu JR
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29565268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hinokitiol Inhibits Melanogenesis via AKT/mTOR Signaling in B16F10 Mouse Melanoma Cells.
    Tsao YT; Huang YF; Kuo CY; Lin YC; Chiang WC; Wang WK; Hsu CW; Lee CH
    Int J Mol Sci; 2016 Feb; 17(2):248. PubMed ID: 26901194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hinokitiol induces autophagy in murine breast and colorectal cancer cells.
    Wang WK; Lin ST; Chang WW; Liu LW; Li TY; Kuo CY; Hsieh JL; Lee CH
    Environ Toxicol; 2016 Jan; 31(1):77-84. PubMed ID: 25044443
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hinokitiol suppresses growth of B16 melanoma by activating ERK/MKP3/proteosome pathway to downregulate survivin expression.
    Wei KC; Chen RF; Chen YF; Lin CH
    Toxicol Appl Pharmacol; 2019 Mar; 366():35-45. PubMed ID: 30684529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crude extract of Rheum palmatum L. Induces cell cycle arrest S phase and apoptosis through mitochondrial-dependent pathways in U-2 OS human osteosarcoma cells.
    Lin CC; Lee MH; Lin JH; Lin ML; Chueh FS; Yu CC; Lin JP; Chou YC; Hsu SC; Chung JG
    Environ Toxicol; 2016 Aug; 31(8):957-69. PubMed ID: 25689151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiproliferative Activity of Hinokitiol, a Tropolone Derivative, Is Mediated via the Inductions of p-JNK and p-PLCĪ³1 Signaling in PDGF-BB-Stimulated Vascular Smooth Muscle Cells.
    Yang PS; Wang MJ; Jayakumar T; Chou DS; Ko CY; Hsu MJ; Hsieh CY
    Molecules; 2015 May; 20(5):8198-212. PubMed ID: 25961161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective Role of Hinokitiol Against H
    Xu Y; Wang S; Miao Q; Jin K; Lou L; Ye X; Xi Y; Ye J
    Curr Eye Res; 2017 Jan; 42(1):47-53. PubMed ID: 27269503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function.
    Liu S; Yamauchi H
    Cancer Lett; 2009 Dec; 286(2):240-9. PubMed ID: 19631451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell cycle arrest and apoptosis induced by aspidin PB through the p53/p21 and mitochondria-dependent pathways in human osteosarcoma cells.
    Wan D; Jiang C; Hua X; Wang T; Chai Y
    Anticancer Drugs; 2015 Oct; 26(9):931-41. PubMed ID: 26181229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hinokitiol induces DNA demethylation via DNMT1 and UHRF1 inhibition in colon cancer cells.
    Seo JS; Choi YH; Moon JW; Kim HS; Park SH
    BMC Cell Biol; 2017 Feb; 18(1):14. PubMed ID: 28241740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the Cytotoxic Activity of Hinokitiol from Drug-Loaded Phytosomal Formulation Against Breast Cancer Cell Lines.
    Ahmed TA; Milibary GA; Almehmady AM; Alahmadi AA; Ali EMM; El-Say KM
    Int J Nanomedicine; 2024; 19():10321-10339. PubMed ID: 39415963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
    Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
    Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.